Nanjing Gaoke Company Limited

Equities

600064

CNE000000PX6

Real Estate Development & Operations

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.43 CNY +0.47% Intraday chart for Nanjing Gaoke Company Limited -1.68% +6.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Nanjing Gaoke Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nanjing Gaoke's Q4 Contracted Sales Drop 69% MT
Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nanjing Gaoke Raises 500 Million Yuan From 180-Day Bond Sale MT
Nanjing Gaoke Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Nanjing Gaoke Issues Ultra-Short-Term Bonds of 900 Million Yuan MT
Nanjing Gaoke Issues 350 Million Yuan Ultra-Short-Term Bonds MT
Nanjing Gaoke Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Nanjing Gaoke Company Limited(XSSC:600064) added to S&P Global BMI Index CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Nanjing Gaoke Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Nanjing TianYiHeXin Electronics Co.,Ltd. announced that it has received $31.4 million in funding from a group of investors CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Nanjing Cyber Peace Tech Co., Ltd announced that it has received $31 million in funding from Nanjing Gaoke Company Limited, Nanjing Dongpingheng Investment Management Co., Ltd., Jiangsu Addor Equity Investment Fund Management Co., Ltd. CI
Njing Hanxin Pharmaceutical Technology Co., Ltd. intends to acquire 51% stake in Nanjing Cuccess Pharmaceutical Co., Ltd. from Nanjing Gaoke Company Limited for approximately CNY 180 million. CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Nanjing Gaoke Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Nanjing Gaoke Company Limited Announces Cash Dividend for 2019, Payable on July 7, 2020 CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Nanjing Gaoke Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Nanjing Gaoke Company Limited Provides Guidance Fro 2019 CI
Chart Nanjing Gaoke Company Limited
More charts
NANJING GAOKE COMPANY LIMITED is a China-based company, principally engaged in real estate and municipal businesses, medical health business and equity investment business. Its real estate business includes residential development, commercial operations and property management, among others. Its medical health business includes the research and development, manufacture and sales of pharmaceuticals. The Company operates its businesses primarily in Nanjing, Jiangsu province, China.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600064 Stock
  4. News Nanjing Gaoke Company Limited
  5. Nanjing Gaoke Issues 350 Million Yuan Ultra-Short-Term Bonds